Rituximab in antiphospholipid syndrome

Affiliations

Comment

Joan T Merrill. Curr Rheumatol Rep. 2003 Oct.

. 2003 Oct;5(5):381-2.

¹ Division of Rheumatology, St. Luke's-Roosevelt Hospital Center, 432 West 58th Street, Antenucci Building, New York, NY 10019, USA. jtm5@columbia.edu

No abstract available

Comment on

Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
Bosly A, Keating MJ, Stasi R, Bradstock K. Bosly A, et al. Anticancer Drugs. 2002 Nov;13 Suppl 2:S25-33. Anticancer Drugs. 2002. PMID: 12710588 Review.

Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
Rückert A, Glimm H, Lübbert M, Grüllich C. Rückert A, et al. Lupus. 2008 Aug;17(8):757-60. doi: 10.1177/0961203307087876. Lupus. 2008. PMID: 18625656
Rituximab treatment for resistant antiphospholipid syndrome.
Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rubenstein E, et al. J Rheumatol. 2006 Feb;33(2):355-7. J Rheumatol. 2006. PMID: 16465669
Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome.
Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Nageswara Rao AA, et al. Pediatr Blood Cancer. 2009 Apr;52(4):536-8. doi: 10.1002/pbc.21878. Pediatr Blood Cancer. 2009. PMID: 19061212
Antiphospholipid antibody syndrome and autoimmune diseases.
Ostrowski RA, Robinson JA. Ostrowski RA, et al. Hematol Oncol Clin North Am. 2008 Feb;22(1):53-65, vi. doi: 10.1016/j.hoc.2007.10.003. Hematol Oncol Clin North Am. 2008. PMID: 18207065 Review.
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld Y, Meroni PL, Toubi E. Shoenfeld Y, et al. Curr Opin Rheumatol. 2009 Sep;21(5):495-500. doi: 10.1097/BOR.0b013e32832effdd. Curr Opin Rheumatol. 2009. PMID: 19593144 Review.